Commercialising drugs in Europe: Lean models for first-time launchers
Launching a product across Europe’s fragmented healthcare systems presents unique challenges that first-timers are often unprepared for, say experts from Cencora. How can emerging biotechs navigate the risks, accelerate market entry, and prevent launches from derailing?
